From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence-Based Policy and Practice

Eduardo Schenberg, Pharmacology Research & Perspectives

Petrie-Flom Center Psychedelic Use, Law, and Spiritual Experience (PULSE) Affiliated Researcher Eduardo Schenberg writes about how the recent review of a new drug application for MDMA-assisted therapy for post traumatic stress disorder by the United States’ Food and Drug Administration (FDA) highlighted epistemological and methodological challenges for evidence assessments.